XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Restricted Stock Units (RSUs)
Common Shares
Common Shares
Restricted Stock Units (RSUs)
Additional
Paid-in
Capital
Additional
Paid-in
Capital
Restricted Stock Units (RSUs)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022     152,135,026        
Beginning balance at Dec. 31, 2022 $ 77,505   $ 1   $ 325,431   $ (247,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common shares issued upon vesting of restricted share units, net of withholding (in shares)       297,888      
Common shares issued upon vesting of restricted share units, net of withholding   $ (69)       $ (69)  
Share-based compensation 375       375    
Net income (loss) (2,912)           (2,912)
Ending balance (in shares) at Mar. 31, 2023     152,432,914        
Ending balance at Mar. 31, 2023 74,899   $ 1   325,737   (250,839)
Beginning balance (in shares) at Dec. 31, 2022     152,135,026        
Beginning balance at Dec. 31, 2022 77,505   $ 1   325,431   (247,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (67)            
Ending balance (in shares) at Jun. 30, 2023     152,825,118        
Ending balance at Jun. 30, 2023 78,361   $ 1   326,355   (247,995)
Beginning balance (in shares) at Mar. 31, 2023     152,432,914        
Beginning balance at Mar. 31, 2023 74,899   $ 1   325,737   (250,839)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common shares issued upon vesting of restricted share units, net of withholding (in shares)       392,204      
Common shares issued upon vesting of restricted share units, net of withholding   (6)       (6)  
Share-based compensation 624       624    
Net income (loss) 2,844           2,844
Ending balance (in shares) at Jun. 30, 2023     152,825,118        
Ending balance at Jun. 30, 2023 $ 78,361   $ 1   326,355   (247,995)
Beginning balance (in shares) at Dec. 31, 2023 154,332,366   154,332,366        
Beginning balance at Dec. 31, 2023 $ 55,558   $ 1   327,280   (271,723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common shares issued upon vesting of restricted share units, net of withholding (in shares)       2,895,489      
Common shares issued upon vesting of restricted share units, net of withholding   (98)       (98)  
Share-based compensation 842       842    
Net income (loss) (9,634)           (9,634)
Ending balance (in shares) at Mar. 31, 2024     157,227,855        
Ending balance at Mar. 31, 2024 $ 46,668   $ 1   328,024   (281,357)
Beginning balance (in shares) at Dec. 31, 2023 154,332,366   154,332,366        
Beginning balance at Dec. 31, 2023 $ 55,558   $ 1   327,280   (271,723)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) $ (20,691)            
Ending balance (in shares) at Jun. 30, 2024 157,495,042   157,495,042        
Ending balance at Jun. 30, 2024 $ 35,828   $ 1   328,241   (292,414)
Beginning balance (in shares) at Mar. 31, 2024     157,227,855        
Beginning balance at Mar. 31, 2024 46,668   $ 1   328,024   (281,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common shares issued upon vesting of restricted share units, net of withholding (in shares)       267,187      
Common shares issued upon vesting of restricted share units, net of withholding   $ (20)       $ (20)  
Share-based compensation 237       237    
Net income (loss) $ (11,057)           (11,057)
Ending balance (in shares) at Jun. 30, 2024 157,495,042   157,495,042        
Ending balance at Jun. 30, 2024 $ 35,828   $ 1   $ 328,241   $ (292,414)